Get access

Risk factors for a non-favorable outcome after treated European neuroborreliosis

Authors


R. Eikeland, Department of Neurology, Sørlandet Hospital HF, Postbox 783, N-4809 Arendal, Norway

Tel.: +4790880246

Fax: +4737014010

e-mail: randi.eikeland@sshf.no

Abstract

Aim

To identify possible risk factors for reduced health-related quality of life (HRQoL) and fatigue after treated Lyme neuroborreliosis (LNB).

Methods

We included 50 patients with LNB and analyzed associations between their demographic, clinical, and laboratory characteristics at baseline and outcome at 30 months assessed by the self-report questionnaires Short Form-36 (SF-36) and Fatigue Severity Scale (FSS).

Results

Lower scores in the SF-36 domain Physical Component Summary were associated with pretreatment symptom duration >6 weeks (B = −11.0, P = 0.001) and non-complete recovery at 4 months (B = −5.5, P = 0.037) (R2 = 0.35). Lower scores in the SF-36 domain Mental Component Summary were associated with non-complete recovery at 4 months (B = −8.9, P = 0.01 (R2 = 0.14). Higher FSS scores were associated with pretreatment symptom duration >6 weeks (B = 1.4, P = 0.006), high scores on the composite clinical score pretreatment (B = 0.1, P = 0.003), and non-complete recovery at 4 months (B = 1.6, P = 0.005) (R2 = 0.46). No laboratory test results were associated with these predefined outcomes.

Conclusions

Delayed treatment start, more symptoms and findings before treatment, and non-complete recovery at 4 months after treatment are possible predictors of a poorer HRQoL and more fatigue 30 months after treated LNB. We did not find age, gender, educational level, involvement of the central nervous system, coexisting diseases, or cerebrospinal fluid findings to be associated with reduced HRQoL or fatigue. Our findings should be replicated in future studies before any conclusions can be drawn.

Ancillary